Patients with myelodysplastic syndrome (MDS) have inef fective in vivo and in vitro erythropoiesis, characterized by an impaired response to erythropoietin (Epo). We examined proliferation and maturation of MDS marrow cells in re sponse to Epo in more detail. Epo-dependent DNA synthesis as well as induction of GATA-1 binding activity in marrow cells from 15 MDS cases were severely reduced as compared with normal bone marrow (NBM). Additionally, the appear ance of morphologically identifiable erythroid cells was de creased in MDS cell cultures. These data indicate that both the Epo-dependent proliferation as well as the differentia tion induction by Epo is suppressed. To study more up stream events of the Epo signal transduction route we inves tigated activation of the signal transducer and activator of transcription (STAT) 5. In all 15 MDS samples tested, STAT5 activation was absent or greatly suppressed in response to Epo. In contrast, interleukin-3 induced a normal STAT5 re sponse in MDS cells. Further, in MDS the subset of CD71+ BM cells that is phenotypicaily similar to Epo-responsive cells in normal marrow, was present. We conclude that the Epo response in MDS is disturbed at an early point in the Epo receptor (EpoR) signal transduction pathway.
HE MYELODYSPLASTIC syndromes (MDS) consti tute a heterogeneous group of disorders of the hemato poietic pluripotent stem cell, characterized by ineffective hematopoiesis.1 In the majority of cases anemia is an early and prominent clinical symptom. In a considerable number of cases the disease progresses to acute leukemia. Bone mar-binding, even though some reports would suggest the possi ble involvement of another receptor chain. 16 '21 Dimerization is essential for receptor function.22'24 Upon binding of Epo, the Janus kinase JAK2 is rapidly activated via the membraneproximal region of the cytoplasmic domain of the receptor.25'27 JAK2 activation leads to the tyrosine-phosphorylation of row (BM) biopsy samples from MDS patients generally several proteins, including the EpoR itself.28'31 Recent data show normocellularity or hypercellularity with active eryth-have shown that one of the activated proteins is STAT5.32, 33 Two forms of STAT5 (STAT5A and STAT5B) derived from ropoiesis. When BM cells from MDS patients are cultured in vitro in the presence of erythropoietin (Epo), the formation of erythroid colonies is reduced as compared with colony formation by cells from normal marrow.2'6 Ineffective eryth ropoiesis is not due to a lack of Epo. Patients with MDS two different genes have been described, which are highly homologous. 34 Preliminary evidence indicates that STAT5 is involved in proliferation signaling from the interleukin-3 (IL-3) receptor.35 Further, it has been suggested that STAT5 have normal or elevated serum levels of Epo,7'8 and treatment may inhibit Epo-induced differentiation. 36 with pharmacological doses of Epo only infrequently im proves the anemia significantly .' J To elucidate the mechanism of impaired erythropoiesis in MDS, we set out to investigate the role of the Epo receptor (EpoR) and its signal transduc tion.
Epo, the major regulator of erythropoiesis, is involved in survival, proliferation, and differentiation of erythroid pro genitors. The EpoR is expressed at relatively low levels on BFU-E (burst-forming units-erythroid, erythroid progeni tors), but expression increases with erythroid maturation to ward late ery throb lasts. EpoRs are lost on more mature ery throid cells.10'1 3 The EpoR is a member of the hemopoietin and cytokine receptor super-family.14,15 It is currently as sumed that the receptor forms a homodimer after ligand From One of the specific events during erythroid differentiation is the expression of the transcription factor GATA-1.37 GATA-1 upregulates the expression of ery thro id-specific genes, including the gene for EpoR and the GATA-1 gene. GATA-1 expression levels are low in progenitor cells, but increase dramatically when the cells are induced to differen tiate along the erythroid lineage.38,39 During differentiation to myeloid cells, expression of GATA-1 is shut off/1 0 When erythroid progenitors derived from normal blood are cultured in the presence of Epo, GATA-1 induction can be shown at day 3.3MI Thus, EpoRs may be upregulated by GATA-1, whereas activation of EpoR may enhance GATA-1 expression.
Recently we have shown that EpoRs are present in normal numbers on marrow cells of patients with MDS, and that the 1 itrand binding capacity of the receptor is intact.4' variants of the receptor have been described.' 14, 45 Submitted GATA-J induction. NBM and MDS cells were incubated over night in liquid medium without growth factor at a cell concentration of 0.5 to 1.0 X 106 cells/mL. The next day the following combina tions of growth factors were added: Epo (1 U/mL), IL-3 (2.5 ng/ mL), stem cell factor (SCF) (100 ng/mL), Epo + IL-3, and Epo + SCF, or none. At the time of harvest, cells were counted, cy to spins were made, and the bulk of cells was used to isolate nuclear proteins. Nuclear extracts were prepared as described.'*5 0 In brief, cells were collected by centrifugation, resuspended in buffer A (10 mmol/L HEPES [pH 7.8], 10 mmol/L KC1, 0.1 mmol/L EDTA, 0.1 mmol/ L EOTA, 1 mmol/L dithiothreitol, 1% Pefabloc SC LBoehringer, Germany 1, 50 /jg/mL aprotinin, 50 ¿tg/tnL leupeptin, 50 /j.g/mL baci tracin, and 50 ¿¿g/mL iodoacetamide) and incubated for 10 minutes on ice. Nonidet P-40 (Sigma, St Louis, MO) was added to a final concentration of 0.6%, and nuclei were spun down for I minute at 10,000#. Nuclear proteins were extracted by i of C Abbreviation: NA, not available.
* Colonies per 10s cells.
STAT5 activation in NBM has a distinct immunophenotype and these cells are present in MDS marrow. STAT-protein activation. After overnight incubation in serum free medium/1 1 ' NBM or MDS cells were procured, counted, and 2 to 5 X 106 cells were incubated for the desired time in the absence or presence of growth factor near extracts were mi as : 100 U/mL. IL-3: 2.5 /./g/ml.). ,i 1 ,1 1 2 leading to Patient material. B M cells were collected from 21 patients with 20 fjL final extract. EM SA was performed in the presence of excess MDS. Patients were classified according to the criteria of the French-American-British (FAB) group as refractory anemia (RA, n = 3), refractory anemia with ring sideroblasts (RA RS, n = 1), refractory anemia with excessive blasts (RA EB , n = 5), refractory anemia with excessive blasts in transformation (RAEB-t, n = 6), and chronic myelomonocytic leukemia (C M M L, n = 6). NBM was obtained from BM transplantation donors after informed consent. Mononu clear cells were collected, and cryopreserved as described pre viously/1 7 Erythroid colony culture. Erythroid 
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results were expressed as the Epo-speciiic sti tained by dividing the counts incorporated in the presence of Epo by the counts incorporated in medium alone. Table 2 
. Fraction of Erythroid Cells Recovered From Epo-Stimulated Cultures of Normal and MDS Marrow
Cells were incubated for 72 hours in the presence of the indicated growth factors. Epo, 1 U/mL; IL-3, 2.5 ng/mL; SCF, 100 ng/mL. Abbreviation: NA, not available. * Case of MDS (see Table 1 ).
a specific competitor |poly(dI-dC)J on 3 ¡uL extract, and probe-protein complexes were separated at 4°C on a 5% polyacrylamide gel in 0.25X TBE, containing 5% glycerol. For supershift assays, specific antibodies were added lor 1 hour before the incubation with probe. Antibodies used were against sheep STAT5,5"' and antibodies against human STAT5A and STAT5B, respectively. STAT5 was detected using a synthetic oligonucleotide probe from the ^-casein promoter (5-AGATTTCTAGGAATTCAATCC-3').54
Analysis of morphology. Differential counts were made on cytospins of 1 to 4 X 104 cells, stained with May-Grimwald-Giemsa. The total amount of cells in the erythroid compartment of a given sample was then obtained by multiplying the absolute cell number with the percentage of erythroid cells. The fraction of recovered erythroid cells was calculated by dividing the total erythroid cells in a sample by the total amount of erythroid cells at t = 0.
Sorting and FACScan analysis. Thirty to 60 X I O'1 NBM cells were labeled in a three-step procedure, 30 minutes per incubation, in phosphate-buffered saline containing 1% BSA and 1% preimmune rabbit serum (PBR). First step, mouse anti-human glycophorin A (GPA) monoclonal antibody; second step, rabbit anti-mouse Ig con jugated with RPE (RAM-PE) (Dako, Glostrup, Denmark); third step, mouse anti-transferrin receptor-FITC (CD71-FITC) (Becton Dickin son, San Jose, CA). In between, cells were washed twice in PBR. As controls, 1 X I0f> cells were labeled with CD71-FITC or GPA/ RAM-PE. Finally, cells were resuspended in PBR, and sorted on a FACSvantage (Becton Dickinson). Analysis of data was done with the Lysis software program (Becton Dickinson). After sorting, cells collected in all four windows were counted, and cytospins were made. The bulk of cells was divided in three portions, and incubated for 15 minutes with no factor, Epo (100 U/mL), or IL-3 (2.5 ¿¿g/mL). Extracts were made as described above, leading to 10 pL final volume. EMSA was performed with 5 to 7 ¡jL extract, in the same way as described above. For analysis of transferrin receptor-and glycophorin A-expression, I to 2 X 106 cells from N BM and M DS patients were labeled in the same way with CD71-FITC and GPA/RAM-PE. Samples were analyzed on a FACScan (Becton Dickinson). Analysis of data was done with the Lysis software program. Windows were designed on NBM samples, and also used for the analysis of MDS patient material. 
RESULTS
Erythroid colony formation and DNA synthesis in re sponse to Epo. The clinical data and in vitro colony forma tion of the patients with MDS are listed in Table 1 . All MDS patients except for case 4 showed impaired erythroid colony formation after Epo stimulation (mean, 22 ± 50 colonies/ 10s cells). For NBM, the numbers of erythroid colonies under identical conditions varied between 105 and 1,115 per 105 cells (mean, 454 ± 281; n = 11). Because erythroid colony formation is the result of both proliferation and differentia tion of progenitor cells, an attempt was made to assess these processes separately. The proliferative response to Epo was measured at day 3 using the 3H-TdR assay. As can be seen in Erythroid differentiation and GATA-1 induction. To in vestigate the early stages of erythroid differentiation in MDS more closely, we analyzed the appearance of morphologi cally identifiable erythroid cells. NBM cultures stimulated with Epo, Epo + IL-3, or Epo + SCF contained increased fractions of erythroid cells at day 3 as compared to control cultures with no factor, IL-3» or SCF ( Table 2) , indicating that Epo is necessary for induction of erythroid differentia tion in these cells. In MDS cases Epo did not stimulate an expansion of the fraction of erythroid cells ( Table 2 ). In addition, we assessed the induction of GATA-1 after Epo exposure of BM cells. Nuclear extracts of equal cell numbers obtained at day 0 and day 3 were assayed for the presence of GATA-1 protein (Fig 2) . In NBM cells, GATA-binding protein was detectable after 3 days in cultures that contained Epo (Fig 2, lanes 3, 4, and 5 ). Under the same conditions GATA-1 was only minimally upregulated in certain MDS Table 3 ).
These results indicate that MDS marrow cells show an impaired Epo response, both with regard to proliferation, as evident from the activation of DNA synthesis, and differenti ation, as apparent from GATA-1-induction and evaluation of morphology. STAT5 activation in NBM. Induction of STAT5 DNAbinding by Epo was assessed in EMSA using the ^-casein probe, which specifically recognizes activated STATS.'1 -1 In a time-course experiment, the probe-protein complex was already detectable at 5 minutes, and persisted for 3 hours after stimulation of NBM cells ( Fig 3A) . Also, incubation with IL-3 (15 minutes) induced the activation of a STAT5 DNA-binding activity ( Fig 3A, lane 7) . The protein-probe complex was not present in extracts from cells stimulated for 15 minutes without factor ( Fig 3B, lane I ) . In all NBM samples tested (n = 12) Epo-specific induction of STAT5 -proteins. Using this pr binding could be detected (not shown).
STATS activation in MDS marrow cells. We then exam
ined whether STATS was activated after Epo stimulation in marrow cells of 15 MDS cases. The results of these studies are summarized in Table 3 . A representative experiment in cluding 5 MDS cases is shown in Fig 4A. No or minimal STAT5 activation in response to Epo was seen in these cases, whereas IL-3 activated STAT5 normally.
To exclude the possibility that the induction of STATS in MDS was quantitatively normal, blit delayed, cells of two patients were incubated with Epo for prolonged time periods. Even after incubation with Epo for 3 hours, STATS activa tion could not be detected, whereas the IL-3-induced signal was maximal at 15 minutes ( Fig 4B) .
Epo-imluced STATS activation in suhpo cells. To define the subpopulation of cells in which STATS
is activated in response to Epo, and to verify the presence EPO IL3 
(A) Activation of /3-casein probe-binding proteins in NBM at different time points. Cells were obtained and extracted immediately (lane 1) or after incubation with Epo for 5 (lane 2), 15 (lane 3), 30 (lane 4), 60 {lane 5), or 180 (lane 6) minutes, or after incubation for 15 minutes with IL-3 (lane 8). Nuclear extracts of equivalent amounts of NBM cells incubated with the /3-casein probe were run on a nondenaturing polyacrylamide gel. Arrow indicates position of STAT5 complex. (B) Identification of STAT-binding proteins activated by Epo in NBM cells. Nuclear extracts obtained from nonstimulated cells (lane 1) or from cells stimulated for 15 minutes with Epo (lanes 2 through 5) were incubated with the /3-casein probe in the absence (lanes 1 and 2) or presence (lanes 3 through 5} of «-STAT5 antibodies. <*5-1 (lane 3), «-sheep STAT5; «5-2 (lane 4), «-human STAT5A; «5-3 (lane 5), «-human STAT5B. Lower arrow indicates position of STAT5 complex, higher arrow the position of antibody-containing complexes.
of such a population in MDS, marrow cells were analyzed for their expression of CD71 and GPA. These markers distin guish successive stages of erythroid differentiation: early erytbroblasts are CD71 (transferrin receptor)-positive, but glycophorin A (GPA)-negadve (CD71+GPA ), normoblasts have acquired GPA (CD71+ GPA+), and more mature red blood cells have lost the CD71-marker (CD71"GPA+ ).Sfi NBM cells were sorted into four R 1 CD71~GPA~, R2 = CD71+ GPA~, R3 = CD71+ GPA+, and + ulation of cells shows both IL-3-mediated ( Fig 5B, lane 8) as well as Epo-mediated STAT5 activation ( Fig 5B, lane 9) . In CD71+ GPA+ cells STAT5 is inducible with Epo, but not with IL-3 ( Fig 5B, lanes 10 through 12) . Finally, more ma ture CD71~GPA+ cells show no STAT5 activation after Epo stimulation (lanes 13 through 15).
Epo-responsive subpopulation in MDS. We then ana lyzed the expression pattern of CD71 and GPA for eight different MDS patient marrow cells (Fig 6) . Although the CD71 GPA+ ( Fig 5A) . Morphological analysis of patterns of expression of these surface markers are more R4the different fractions confirmed the previously established correlation between cytological stage and cell-surface phe notype (not shown). Sorted fractions were incubated with IL-3, Epo, or without factor. The CD71~GPA~ fraction shows clear STAT5 activation with IL-3 ( Fig 5B, lane 5) , but not with Epo ( Fig 5B, lane 6) . The CD71+ GPA~ subpop-heterogeneous among MDS cases, in all instances consider able numbers of cells with CD71+GPA~ and CD71+ GPA+ expression were present. This indicates that the reactive ery throid progenitor cell subset has not been eliminated in MDS, and thus a quantitative lack of these cells does not explain the reduced Epo-induced STAT5 activation in MDS. (lanes 1, 4 ,7 ,1 0 ,1 3 ,1 6 ) , with IL-3 (lanes 2# 5, 8,11,14, 17 3, 6, 9, 12, 15, 18) . Marrow cells used were obtained from patient 8 (lanes 1 through 3), patient 13 (lanes  4 through 6), patient 2 (lanes 7 through 9), patient 1  (lanes 10 through 12), patient 19 (lanes 13 through  15), patient 7 (lanes 16 through 18) ; patient numbers correlate to case numbers in Table 1 . Nuclear ex tracts were incubated with the ¿Ncasein probe. MDS (patient 13, lanes 1  through 7; and patient 8, lanes 8 through 14) were obtained and extracted after no stimulation (lanes 1  and 8) , or after incubation with Epo for 5 (lanes 2  and 9), 15 (lanes 3 and 10), 30 (lanes 4 and 11), 60  (lanes 5 and 12), or 180 minutes (lanes 6 and 13), or  after incubation for 15 minutes with IL-3 (lanes 7 and  14) . The probe used is the 0-casein probe, and the film was relatively overexposed. Arrow indicates po sition of STATS complex. A) (0, unsorted cells (lanes 1 through 3]; 1,  CD7T and GPA~ cells [lanes 4 through 6]; 2, CD714  and GPA" cells [lanes 7 through 9]; 3, CD71+ and  GPA* cells [lanes 10 through 12]; and 4, CD7T and  GPA* cells [lanes 13 through 15] ) were obtained and extracted after 15 minutes of incubation without fac tor (lanes 1, 4, 1, 10, 13), with IL-3 (lanes 2, 5, 8, 11, (lanes 3, 6, 9, 12, 15 ). Nuclear ex tracts were incubated with the /3-casein probe and analyzed for activation of STAT5 on a nondenaturing polyacrylamide gel. Arrow indicates position of STATS complex.
Fig 4» (A) STAT5 activation in MDS patients cells after incubation with Epo. Equivalent amounts of cells were obtained and extracted after 15 minutes of incubation without factor
), or with Epo (lanes
Arrow indicates position of STATS complex. (B) Acti vation of STAT5 in MDS at different time points. Cells from two patients with
» Fig 5. (A) Flow cytometric analysis of sorted NBM cells, CD71~ and GPA" cells (rectangle 1), CD71H and GPA~ cells (rectangle 2), CD71* and GPA* cells (rect angle 3), CD71-and GPA* cells (rectangle 4). (B) STATS activation in NBM cells sorted for CD71 and GPA expression. Cells sorted according to the win dows in (
14), or with Epo
DISCUSSION
by Epo was also impaired in MDS as assessed by the induc ía this study, we have analyzed the deficient erythroid ^on GATA-binding proteins, and the appearance of erymaturation in MDS in response to Epo as compared with throid cells in culture. As a first possible mechanism, we NBM. Epo-induced DNA synthesis was considerably re-looked for mutations in the EpoR. Table 1. nism of impaired Epo responsiveness (see Table 3 , and data not shown).
The relation between Epo stimulation and the role of GATA-1 is complex, and the hierarchy of cellular events during erythroid development has not been fully elucidated. However, it is clear that upregulation of GATA-1 expression precedes the increase of EpoR mRNA during erythroid dif ferentiation.'V J Studies with GATA-1" mouse embryonic stem cells have shown that GATA-1 is essential for erythroid cell development.'™'50 GATA-1" precursors are arrested at the proerythroblast stage and undergo premature cell death. A low level of GATA-1, present in early progenitors,1<V K W 1 may induce a low level of EpoR expression. A GATA-1 binding site is present in the EpoR promoter, and this site is involved in high-level tissue specific expression of the EpoR.61,62 Studies in knock-out mice with a deleted gene of either the EpoR or Epo have shown that Epo is not necessary for erythroid commitment, but it is essential for the prolifera tion and differentiation of committed progenitors.63 Epo stimulation of normal erythroid progenitors leads to an upregulation of GATA-1 expression (Fig 2-1ii'41 ). Since we have shown that normal levels of EpoR, capable of binding their natural ligand, are present on MDS cells,43 it is less likely that a primary GATA-1 block and suppression of Epo-R expression during differentiation play a dominant role in the reduced erythropoiesis.
A lack of STAT5 activation after Epo stimulation was apparent in 11 of 15 MDS patients, and it was low in 4 of 15 patients. In contrast, activation of STATS by Epo could always be detected in NBM cells. Although it has been rethat Epo can activate STATl in certain cell lines/"1 our studies in primary BM cells show only activation of STAT5 by Epo. Extended incubation times showed that the response is detectable after 5 minutes, it is maximal at 15 minutes, and it remains up to 3 hours. At none of these time points could STATS activation be detected in MDS. Recent data using dominant-negative mutants of STAT5,1 s and anti sense approaches36 underscore the importance of STAT5 for mediating proliferation signals of the IL-3 receptor and the EpoR, respectively. In our studies, reduced or absent STATS activation correlated with an impairment of DNA synthesis and with inhibited erythroid colony-forming capacity of MDS marrow in all instances (see Ti 3). The Epo-mediated STAT5 activation could be assigned to a specific subpopulation of erythroid levels of CD71\ CD71' in c numbers in all MDS samples tested. Thus, paucity of cells with the Epo-responsive phenotype cannot explain the abnor mal Epo e, we c 2 that the re :ed STAT5 response in gnaling of the EpoR at an early level. The experiments reported here are a first step toward un derstanding at which level the cascade of the Epo signaling is disturbed in MDS. In this report we have used STATS and GATA1 as monitors for the activation of the EpoR to tion of the Epo-mediated mitogenic response. However, localize the level at which this response is inhibited. The screening of the primary sequence of the EpoR of a number nature of these studies is descriptive, as is fre of Epo-unresponsive MDS cases (it = I ()) did not provide case evidence for an abnormal EpoR structure as a general mecha-Nevertheless, the studies cannot menologic, because it has been established that inhibition of STAT5 and GATA I interferes with Epo-induced cell prolif eration and survival.35" '6,30,50 In contrast, this has as yet not been reported for Epo-induced MAP kinase and P13K acti vation. We do not suggest that the inhibited Epo response is an effect specific of STAT5. Failure to activate STAT5, for instance, could be related to a deficiency in JAK2 activation. Activation of JAK2 may also be necessary for the activation of the mi-pathway,65 so that multiple pathways downstream of JAK2 in MDS could be deficient, including the ras/ MAPK66,67 and PI3K-routes.68"71 Measurements of the activa tion of these molecules by immunoprecipitation procedures are hampered by the limited amount of patient material avail able. Although our data suggest that the inhibited STAT5 response is a crucial step in the arrest of mitogenesis of erythropoietic cells, thus leading to suppressed erythropoiesis, other mechanisms interfering with Epo responsiveness should be considered as well. These may involve additional molecules known to become activated after stimulation with Epo. Notably, the tyrosine phosphatase Syp (SHPTP1D)72 is tyrosine-phosphorylated and associates with the EpoR after Epo stimulation. For the prolactin receptor it has been shown that Syp has a positive effect on signal transduction.73 In analogy, inability to activate Syp could lead to an impaired Epo response. Alternatively, overactivation of another tyro sine phosphatase, hematopoietic cell phosphatase (HCP, PTP1C), could downregulate the Epo-mediated signal,74 leading to a reduced Epo response. In addition, the activation of receptors that act upstream in developmental pathways may interfere with the function of more downstream recep tors.75 All of these signaling pathways deserve a careful anal ysis in future studies dealing with the disturbed erythroid development in MDS. 
